Market Report -- In Play (WIRES)
MSN Money - USA
Opexa Therapeutics (OPXA) provides an update on its 150-patient Phase IIb safety and efficacy study of Tovaxin in multiple sclerosis. ...
See all stories on this topic

Opexa Therapeutics Reveals Steady Progress Of Phase IIb Trial Of ...
Trading Markets - Los Angeles,CA,USA
(RTTNews) - Opexa Therapeutics, Inc. (OPXA | charts | news | PowerRating) on Tuesday revealed additional details on its 150-patient Phase IIb safety and ...
See all stories on this topic